Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities.

Source:http://linkedlifedata.com/resource/pubmed/id/21714538

J. Med. Chem. 2011 Aug 11 54 15 5532-9

Download in:

View as

General Info

PMID
21714538